FDA approval of oncology drugs in association of relative survival benefits - An analysis of the oncology drug applications over the 10 years

Journal article

Peer reviewed

N. Young-Lin, I. Amanam, T. Kiet, K. Blansit, D. Kapp, B. Monk, D. Hoth and J. Chan

Gynecologic oncology, Vol.130(1), pp.e99-e99

07/2013

Metrics

4 Record Views

Title: FDA approval of oncology drugs in association of relative survival benefits - An analysis of the oncology drug applications over the 10 years
Creators: N. Young-Lin - UCSF Helen Diller Family Comprehensive Cancer Center
I. Amanam - UCSF Helen Diller Family Comprehensive Cancer Center
T. Kiet - UCSF Helen Diller Family Comprehensive Cancer Center
K. Blansit - UCSF Helen Diller Family Comprehensive Cancer Center
D. Kapp - Stanford University
B. Monk - Creighton University
D. Hoth - UCSF Helen Diller Family Comprehensive Cancer Center
J. Chan - UCSF Helen Diller Family Comprehensive Cancer Center
Publication Details: Gynecologic oncology, Vol.130(1), pp.e99-e99
Publisher: Elsevier Inc
Identifiers: 991005969004802656
Academic Unit: Obstetrics & Gynecology
Language: English
Resource Type: Journal article